Financhill
Back

Perspective Therapeutics Stock Price Chart

Sell
43

CATX
Perspective Therapeutics

Last Price:
1.36
Seasonality Move:
17.15%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

Perspective Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.53 Sell
20-day SMA: 1.65 Sell
50-day SMA: 1.52 Sell
200-day SMA: 0.74 Buy
8-day EMA: 1.52 Sell
20-day EMA: 1.58 Sell
50-day EMA: 1.47 Sell
200-day EMA: 0.95 Buy

Perspective Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 36.33 Sell
Chaikin Money Flow: -6008934 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.53 - 1.77) Sell
Bollinger Bands (100): (0.77 - 1.57) Buy

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Perspective Therapeutics Stock

Is Perspective Therapeutics Stock a Buy?

CATX Technical Analysis vs Fundamental Analysis

Sell
43
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy or a Sell?

Perspective Therapeutics Stock Info

Market Cap:
840.55M
Price in USD:
1.35
Share Volume:
11.15M

Perspective Therapeutics 52-Week Range

52-Week High:
1.91
52-Week Low:
0.21
Sell
43
Perspective Therapeutics (CATX) is a Sell

Perspective Therapeutics Share Price Forecast

Is Perspective Therapeutics Stock a Buy?

Fundamental Analysis of Perspective Therapeutics

Is Perspective Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Technical Analysis of Perspective Therapeutics

Should I short Perspective Therapeutics stock?

* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.